Unity Biotechnology Inc (UBX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9770 -0.0067 (-0.68%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0200 +0.0430 (+4.40%) 16:21 ET
for Fri, Apr 25th, 2025
Results
download Want to compare other data? Select Fields| Symbol | UBX | EDSA | CMMB | ||
| Company | Unity Biotechnology Inc | Edesa Biotech Inc | Chemomab Therapeutics Ltd ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.0000 | 2.39 | 1.2900 | ||
| High | 1.0400 | 2.39 | 1.3500 | ||
| Low | 0.9760 | 2.33 | 1.2804 | ||
| Last | 0.9770 | 2.36 | 1.3100 | ||
| Change | -0.0067 | +0.01 | +0.0200 | ||
| % Change | -0.68% | +0.43% | +1.55% | ||
| Volume | 88,100 | 4,100 | 63,500 | ||
| 20-Day Average Volume | 139,870 | 8,910 | 109,385 | ||
| Previous Close | 0.9837 | 2.35 | 1.2900 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.9772 | 2.32 | 1.1139 | ||
| 20-Day Raw Stochastic | 33.78% | 61.70% | 91.29% | ||
| 20-Day Relative Strength | 38.07% | 51.56% | 51.70% | ||
| Weighted Alpha | -48.40 | -52.10 | +26.21 | ||
| Today's Opinion | 88% Sell | 40% Sell | 64% Sell | ||
| Previous Opinion | 88% Sell | 40% Sell | 64% Sell | ||
| Last Month's Opinion | 8% Sell | 8% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.72% since 04/17/25 | +4.42% since 04/17/25 | +16.96% since 04/17/25 | ||
| Low | 0.9102 on 04/21/25 | 2.26 on 04/21/25 | 1.0800 on 04/21/25 | ||
| High | 1.0400 on 04/25/25 | 2.40 on 04/24/25 | 1.3500 on 04/25/25 | ||
| 1-Month | |||||
| %Chg | -22.77% since 03/25/25 | -5.22% since 03/25/25 | +14.91% since 03/25/25 | ||
| Low | 0.8531 on 04/08/25 | 2.07 on 04/07/25 | 0.8905 on 04/10/25 | ||
| High | 1.2700 on 03/26/25 | 2.55 on 03/27/25 | 1.3500 on 04/25/25 | ||
| 3-Month | |||||
| %Chg | -58.95% since 01/24/25 | +5.83% since 01/24/25 | -37.02% since 01/24/25 | ||
| Low | 0.8531 on 04/08/25 | 1.80 on 01/27/25 | 0.8905 on 04/10/25 | ||
| High | 2.4500 on 01/28/25 | 4.49 on 02/13/25 | 2.1900 on 02/05/25 | ||
| 6-Month | |||||
| %Chg | -27.09% since 10/25/24 | -30.59% since 10/25/24 | -9.03% since 10/25/24 | ||
| Low | 0.8531 on 04/08/25 | 1.55 on 12/20/24 | 0.8905 on 04/10/25 | ||
| High | 3.1000 on 01/23/25 | 4.49 on 02/13/25 | 2.4600 on 01/07/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,491 | 16,222 | 15,077 | ||
| Shares Outstanding, K | 17,212 | 7,023 | 14,359 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -25,990,000 | -6,170,000 | -13,950,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -8,440,000 | -1,620,000 | -2,960,000 | ||
| 60-Month Beta | 1.30 | 0.60 | 0.66 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.43 on 04/22/25 | -0.48 on 02/14/25 | -0.16 on 03/03/25 | ||
| Latest Earnings Date | 05/13/25 | 05/09/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||